Related Experiment Videos
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
J M Graham1, M N Paley, R A Grünewald
1Academic Department of Radiology and Section of Clinical Neurology, University of Sheffield, Sheffield, UK.
Abstract:
Iron content of the basal ganglia was investigated in 25 patients with idiopathic Parkinson's disease and 14 matched healthy control subjects using a partially refocused interleaved multiple echo sequence on a 1.5 Tesla MRI system. R(2)* (1/T(2)*) and R(2)' (1/T(2)') relaxation rates were higher in the substantia nigra of patients with Parkinson's disease, which indicates that iron content is elevated in this region. R(2)' was lower in the putamen, indicating reduced iron levels; reduction in this region was positively correlated with disease duration. Iron-related oxidative stress may contribute to the neurodegeneration of Parkinson's disease, which may lead to alterations in the iron levels of the striatum. We describe a simple, non-invasive technique for measuring iron content.
Insights
Parkinson's disease patients show elevated iron in the substantia nigra and reduced iron in the putamen, correlating with disease duration. This non-invasive MRI technique reveals potential iron-related oxidative stress contributing to neurodegeneration.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Biochemistry
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms.
- Iron accumulation in the brain is implicated in PD pathogenesis.
- Understanding iron's role in PD is crucial for developing effective treatments.
Purpose of the Study:
- To investigate iron content in the basal ganglia of Parkinson's disease patients.
- To correlate iron levels with disease duration and severity.
- To assess the utility of MRI for non-invasively measuring brain iron.
Main Methods:
- Utilized a partially refocused interleaved multiple echo sequence on a 1.5 Tesla MRI system.
- Measured R(2)* and R(2)' relaxation rates in the substantia nigra and putamen.
- Compared iron-related relaxation rates between 25 PD patients and 14 healthy controls.
Main Results:
- Elevated R(2)* and R(2)' rates in the substantia nigra of PD patients, indicating increased iron.
- Lower R(2)' rates in the putamen of PD patients, suggesting reduced iron.
- Putamenal iron reduction positively correlated with Parkinson's disease duration.
Conclusions:
- Iron dysregulation in the basal ganglia is evident in Parkinson's disease.
- Iron accumulation in the substantia nigra and reduction in the putamen may be key features of PD.
- MRI offers a non-invasive method to quantify brain iron, aiding in understanding PD pathophysiology.